ArticleFrontiers in pharmacology2025
Integrated effects of Kampo treatment on gastrointestinal symptoms and stress in patients with functional dyspepsia: a preliminary prospective observational study.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intervention WithFood science & nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This preliminary, single-center prospective observational study aimed to investigate the effects of Kampo treatment on improving gastrointestinal symptoms and reducing stress levels in patients with Functional Dyspepsia (FD). Methods: Adult patients diagnosed with FD were included and their background characteristics were collected using a Fundamental State Questionnaire. The Gastrointestinal Symptom Rating Scale (GSRS) was used to assess gastrointestinal symptom improvement, and the Profile of Mood States Second Edition-Adult Short Form (POMS-2A) was used to evaluate stress relief both before and after treatment. Paired t-tests were used to compare the GSRS and POMS-2A scores before and after treatment. One-way ANOVA was applied to explore whether there were differences in efficacy among the three Kampo formulas, while Multiple linear regression was used to analyze the associations between patient characteristics and treatment outcomes. Results: Forty-one patients with FD were included, and thirty-three were included in the final analysis (N = 41, n = 33 analyzed). Following an average of 52 days of Kampo treatment (bukuryoin, heiisan, rikkunshito), there was a significant improvement in gastrointestinal symptoms, such as hunger, pain, constipation, and gastrectasia, as well as overall symptoms. Additionally, there was a significant decrease in negative mood components (anger and depression) and total mood disturbance. Marital status, smoking habits and sleep quality may serve as significant factors influencing the outcomes of Kampo treatment. Conclusion: In this exploratory and preliminary study, following Kampo treatment (bukuryoin, heiisan, rikkunshito), the trend of improvements in gastrointestinal symptoms and stress levels were observed in patients with FD. Additionally, marital status, smoking habits and sleep quality may serve as significant factors influencing treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.